|
1
|
Response to sorafenib at a low dose in patients with radioiodine-refractory pulmonary metastases from papillary thyroid carcinoma.
|
Thyroid
|
2010
|
1.04
|
|
2
|
Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
|
J Nucl Med
|
2008
|
0.94
|
|
3
|
The role of radionuclide lymphoscintigraphy in extremity lymphedema.
|
Ann Nucl Med
|
2006
|
0.93
|
|
4
|
Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib.
|
Thyroid
|
2012
|
0.84
|
|
5
|
Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
|
Thyroid
|
2010
|
0.80
|
|
6
|
The role of radionuclide lymphoscintigraphy in chyluria.
|
Hell J Nucl Med
|
2011
|
0.79
|
|
7
|
Anatomic and metabolic imaging of venous thromboembolism mimicking thyroid carcinoma extension.
|
J Thromb Thrombolysis
|
2010
|
0.75
|